Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HORMONE REPLACEMENT CLINICAL TRIALS NEEDED FOR "DEFINITIVE" BREAST CANCER RISK DATA -- NIH RESPONSE TO NURSES' HEALTH STUDY FOLLOW-UP ON HORMONES

Executive Summary

Clinical trials of hormone replacement therapies are needed to achieve "definitive" breast cancer risk data, the National Institutes of Health asserted June 14 in response to publication of follow-up data from the Nurses' Health Study in the June 15 New England Journal of Medicine by Graham Colditz, MD, et. al., Brigham & Women's Hospital and Harvard Medical School.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026370

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel